Feb. 6 at 11:24 AM
$PRPH Equivir (OTC):
The study demonstrates a clinically studied dietary supplement with significant potential. Commercialization to be determined.
Aha, now Equivir is being used as bait again. According to Ted, it used to be worth billions in his many hours of storytelling. And who is the long-time loyal investor that Ted is so disappointed in, I think? ThinkEquity https://ap.lc/EpjDN.🕵️♂️🕵️♂️🥷🥷🦮🦮
https://d1io3yog0oux5.cloudfront.net/_16a77ab1cb06df0ad21347ebff0e0976/prophaselabs/db/1323/12302/pdf/ProPhase+Labs+Presentation+%28Website+Version%29+2026-0205.pdf